Independent fund research. Built on SEC filings.

How we research funds

Fidelity · Technology Sector

Fidelity Advisor Biotechnology Fund: share classes compared

Fidelity Advisor Biotechnology Fund has 5 share classes. They hold the same portfolio — $2.2 billion in total — but charge different fees and loads. The cheapest is FIJYX (Class Z) at 0.57%.

TickerShare classTypeExpense ratioFront load12b-11-yr5-yr10-yr
FBTAXClass AMutual fund 0.94%—0.25% +31.5%+6.4%+7.7%
FBTIXClass IMutual fund 0.69%—0% +39.9%+7.9%+8.6%
FBTTXClass MMutual fund 1.19%—0.5% +34.4%+6.6%+7.6%
FBTCXClass CMutual fund 1.69%—1% +37.5%+6.8%+7.7%
FIJYXClass ZMutual fund 0.57%—0% +40.1%+8.1%—

Source: Fund prospectus, filed Sep 24, 2026

Objective

Fidelity Advisor Biotechnology Fund seeks capital appreciation.

Top holdings

  1. Abbvie Inc — 14.71%
  2. Gilead Sciences Inc — 5.70%
  3. Spyre Therapeutics Inc — 3.83%
  4. Alnylam Pharmaceuticals Inc — 3.62%
  5. Dianthus Therapeutics Inc — 3.55%
  6. Cogent Biosciences Inc — 3.25%
  7. Oruka Therapeutics Inc — 3.24%
  8. Insmed Inc — 3.05%
  9. Revolution Medicines Inc — 3.00%
  10. Argenx Se — 3.00%